Velodyne Lidar Showcases Full Stack Vision Solutions for Robotics, Industrial and Trucking at XPONENTIAL 2022
20.4.2022 13:48:00 EEST | Business Wire | Press release
Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) will demonstrate its innovative lidar sensors and software at XPONENTIAL 2022 in Orlando from April 26 to 28 – booth #2149. Velodyne will highlight how its lidar technology powers autonomous solutions in robotics, industrial, trucking and more that are advancing safety, sustainability, efficiency and equity on a global scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220420005427/en/
Velodyne Lidar will demonstrate its innovative lidar sensors and software at XPONENTIAL 2022 – booth #2149. Velodyne will display its cutting-edge Velarray M1600, Puck and Ultra Puck sensors that provide companies the performance, reliability and scalability needed in a wide range of applications. It will also show the Vella Development Kit which allows customers to plug in Velodyne’s lidar with an off-the-shelf library of perception software functions. (Photo: Velodyne Lidar)
Supply chain capacity issues, roadway congestion, safety concerns and labor shortages are driving autonomous system deployments. Velodyne delivers the lidar sensors and software that solve customers’ system-level challenges to develop full-stack autonomous solutions and accelerate their time to market.
At XPONENTIAL, Velodyne will display its cutting-edge Velarray M1600, Puck and Ultra Puck sensors that provide companies the performance, reliability and scalability needed in a wide range of applications. It will also show the Vella Development Kit which allows customers to plug in Velodyne’s lidar with an off-the-shelf library of perception software functions, fast tracking their solution development for ever-evolving applications.
Attendees can immerse themselves in an augmented reality (AR) demonstration to experience how Velodyne’s M1600 sensors perceive the world. Additionally, Velodyne will be joined by Clearpath Robotics, which will showcase its Husky Unmanned Ground Vehicle, powered by Velodyne’s Puck, which is engineered to thrive in harsh outdoor, all-terrain environments.
“XPONENTIAL attendees can see how Velodyne’s sensor and software portfolio is shaping the wave of autonomous solution commercialization taking place in the industrial, robotics and automotive sectors,” said Sally Frykman, Chief Marketing Officer, Velodyne Lidar. “Now more than ever before, we live in a world in motion. To keep pace, industries are deploying smarter technology. Companies can rely on our lidar-based solutions to help their automated systems transform lives and make communities safer.”
How Lidar Solutions Advance Roadway and Supply Chain Efficiency
At the XPONENTIAL conference, Christina Aizcorbe, Velodyne’s Vice President of Government Affairs, will speak on a panel on the commercialization of automated trucking. Mrs. Aizcorbe will discuss how current automated trucking deployments are not just proving out a theoretical concept. They are bringing critical and credible real-world data which will support expansion, making the benefits that will come with commercialization very real to U.S. consumers. Innovation in freight and cargo movement will also spur economic growth well beyond trucking.
The session, called “What Does the Commercialization of Automated Trucking Look Like? – Part 2,” takes place on April 25 from 2:50 p.m. to 3:45 p.m. EDT at Room S330A/B.
“We are seeing rapid growth in automation across other parts of the supply chain, like the use of the same advanced sensing technologies used in automated driving systems to improve efficiency in warehouse and logistics operations, and port automation. Lidar technology is essential to ensuring sensor redundancy and around the clock safe performance of these systems,” said Mrs. Aizcorbe.
To schedule an XPONENTIAL meeting at the Velodyne booth, contact Velodyne Sales: 669.275.2526, sales@velodyne.com.
About Velodyne Lidar
Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality, and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.
Forward Looking Statements
This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005427/en/
Contact information
Velodyne Investor Relations
InvestorRelations@velodyne.com
Media
Codeword
Liv Allen
velodyne@codewordagency.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
